A vial labelled with the Pfizer-BioNTech coronavirus illness (COVID-19) vaccine is seen on this illustration image taken March 19, 2021. REUTERS/Dado Ruvic/File Picture
Oct 28 (Reuters) – Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) stated on Thursday they anticipate to ship 50 million extra doses of their COVID-19 vaccine to the U.S. authorities by April-end, because the nation prepares for vaccinating kids.
Reporting by Manojna Maddipatla in Bengaluru; Modifying by Shounak Dasgupta
Our Requirements: The Thomson Reuters Trust Principles.
0 Comments